Thursday February 21, 2019
Home India First Indian ...

First Indian doctor in last 5 years and Ex AIIMS head M C Misra Awarded honorary fellowship of prestigious Royal College of Surgeons of Edinburgh

0
//
Former AIIMS Director and internationally renowned surgeon M.C. Misra. VOA

New Delhi, May 24, 2017: Former AIIMS Director and internationally renowned surgeon M.C. Misra has been awarded the honorary fellowship of prestigious Royal College of Surgeons of Edinburgh, a first for an Indian doctor in the last five years.

The announcement was made on Tuesday evening.

“It is with great pleasure, we write on behalf of Royal College of Surgeons of Edinburgh to invite you to accept the award of fellowship ad hominem (Honorary fellowship),” reads the letter for Misra to convey the honor by the premier organization.

NewsGram brings to you latest new stories in India.

The Royal College of Surgeons of Edinburgh is an organization dedicated to the pursuit of excellence and advancement in surgical practice, through its interest in education, training, and examinations, its liaison with external medical bodies and representation of the modern surgical workforce.

The Royal College of Surgeons in Edinburgh is one of the oldest surgical corporations in the world and traces its origins to 1505 when the Barber Surgeons of Edinburgh were formally incorporated as a craft guild of Edinburgh.

Follow NewsGram on Facebook

Today, the Royal College of Surgeons of Edinburgh is an international network with a membership of almost 20,000, in almost 100 countries.

Misra, also a globally renowned trauma expert, retired on January 31, 2017 after serving All India Institute of Medical Sciences (AIIMS) as its director for more than three years. (IANS)

Next Story

HPV Vaccination May Bring An End To Cervical Cancer In India by 2070

Combining high uptake of the HPV vaccine and cervical screening could eliminate cervical cancer as a public health hazard in 149 out of 181 countries by 2100 and up to 13 million cases of cervical cancer by 2050.

0
cancer
Cervical cancer is the fourth-most common cancer among women, with an estimated 570,000 new cases diagnosed worldwide in 2018, of which around 85 per cent occur in less developed nations. Pixabay

Human papillomavirus (HPV) screening and vaccination must be taken up on a war footing in countries like India to prevent 15 million cervical cancer deaths among women by 2050, a Lancet research said.

Causing the second-highest number of deaths among Indian women among cancer variants, cervical cancer, in a majority of cases, is caused by HPV, a group of more than 150 viruses.

The efforts might even result in cervical cancer being eliminated as a public health hazard in India by 2070-79, according to the study, published in The Lancet Oncology journal.

Combining high uptake of the HPV vaccine and cervical screening could eliminate cervical cancer as a public health hazard in 149 out of 181 countries by 2100 and up to 13 million cases of cervical cancer by 2050.

Cancer
“Awareness about cervical cancer is extremely poor among common people; that makes containing the disease a challenge,” Anjila Aneja, Director at Fortis La Femme, New Delhi, told IANS. Pixabay

If the high coverage of HPV vaccination and cervical screening cannot be achieved globally, over 44 million women could be diagnosed with cervical cancer in the next 50 years with two-thirds of these cases and an additional estimated 15 million deaths, would occur in countries with low and medium levels of development.

“More than two thirds of cases prevented would be in countries with low and medium levels of human development like India, Nigeria, and Malawi, where there has so far been limited access to HPV vaccination or cervical screening,” said lead author Professor Karen Canfell from the Cancer Council New South Wales in Australia.

However, large disparities exist in cervical screening and HPV vaccination coverage among countries.

“Awareness about cervical cancer is extremely poor among common people; that makes containing the disease a challenge,” Anjila Aneja, Director at Fortis La Femme, New Delhi, told IANS.

“While societal barriers prevent women from seeking medical help in advance, women are forced to come out at a later stage when the disease has reached an advanced stage,” she said.

cancer
Screening and broad-spectrum HPV vaccines could potentially prevent up to 84-90 per cent of cervical cancers, the study said. Pixabay

However, Canfell says that despite the enormity of the problem, their findings suggest that “global elimination is within reach with tools that are already available, provided that both high coverage of HPV vaccination and cervical screening can be achieved.

Cervical cancer is the fourth-most common cancer among women, with an estimated 570,000 new cases diagnosed worldwide in 2018, of which around 85 per cent occur in less developed nations.

Screening and broad-spectrum HPV vaccines could potentially prevent up to 84-90 per cent of cervical cancers, the study said.

Also Read: Indian IT Act Silent On Social Media’s Manipulative Role
“Diagnostic tests such as the pap smear are effective in identifying cancerous tendencies.

“However, these tests are available with a limited number of providers and largely within the cities. This makes screening sporadic and leaves out women who live in rural areas,” Aneja added. (IANS)